Search results for "AGLA"

showing 10 items of 272 documents

Anti-inflammatory properties of hydroalcoholic extracts of Argentine Puna plants

2015

The aim of this study is to evaluate the activity of thirteen hydroalcoholic extracts obtained from aerial parts of plants from Argentina Puna on pro-inflammatory enzymes and inflammatory mediators. Eleven extracts were non-cytotoxic on RAW 264.7. Data obtained suggest the capacity of these Argentine Puna plant extracts to inhibit the production of inflammatory mediators (nitric oxide and prostaglandin) at different levels. The plant extracts can affect enzymes expression and/or enzymes activity, and they can also act by NO scavenging. Each extract exerts its anti-inflammatory effect through different mechanisms. The inhibitory ability on pro-inflammatory enzymes by these hydroalcoholic ext…

PUNA PLANT SPECIESNITRIC OXIDE SYNTHASEmedicine.drug_classProstaglandinBiologyAnti-inflammatoryNitric oxideCYCLOOXYGENASE-2Ciencias Biológicaschemistry.chemical_compoundmedicinechemistry.chemical_classificationTraditional medicinePROSTAGLANDINfungifood and beveragesBioquímica y Biología Molecularbiology.organism_classificationEnzyme assayNitric oxide synthaseEnzymechemistryBiochemistryToxicitybiology.proteinArtemia salinaNITRIC OXIDECIENCIAS NATURALES Y EXACTASFood ScienceFood Research International
researchProduct

Latvijas Vēstures Institūta Žurnāls. 2013, Nr. 2 (87)

2013

Valsts kultūrkapitāla fonds

Padomju laika sociālās reprezentācijas Latvijas sabiedriskajā domā:HUMANITIES and RELIGION::History and philosophy subjects::Archaeology subjects [Research Subject Categories]Post-war Latvian Refugees Building Foundations in Diaspora:HUMANITIES and RELIGION::History and philosophy subjects::History subjects [Research Subject Categories]RecenzijasZinātnes dzīveVēstures avotiPieminekļa valdes darbs Rīgas vecpilsētas arhitektūras mantojuma saglabāšanāHeisterbahas Cēzarija vēstījumsPersonālijas
researchProduct

Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.

2013

Background: Prostaglandin E2 (PGE(2)), the main metabolite of cyclooxygenase (COX), is a well-known anti-fibrotic agent. Moreover, myofibroblasts expressing alpha-smooth muscle actin (alpha-SMA), fibroblast expansion and epithelial-mesenchymal transition (EMT) are critical to the pathogenesis of idiopathic pulmonary fibrosis (IPF). Our aim was to investigate the expression of COX-2 and PGE(2) in human lung myofibroblasts and establish whether fibroblast-myofibroblast transition (FMT) and EMT are associated with COX-2 and PGE(2) down-regulation. Methods: Fibroblasts obtained from IPF patients (n = 6) and patients undergoing spontaneous pneumothorax (control, n = 6) and alveolar epithelial ce…

PathologyPulmonologyMetaboliteImmunofluorescencelcsh:MedicineBiochemistrychemistry.chemical_compoundIdiopathic pulmonary fibrosisMolecular Cell BiologyPulmonary fibrosisProstaglandin E2Myofibroblastslcsh:ScienceLungCells CulturedFisiologia cel·lularMultidisciplinarybiologyFibrosi pulmonarrespiratory systemExtracellular Matrixmedicine.anatomical_structureCytokinesMedicinelipids (amino acids peptides and proteins)Immunohistochemical AnalysisMyofibroblastResearch ArticleSignal Transductionmedicine.drugmedicine.medical_specialtyEpithelial-Mesenchymal TransitionImmunologyInterstitial Lung DiseasesDinoprostonePulmonary fibrosisTransforming Growth Factor beta1ImmunofluorescènciaGrowth FactorsCell Line TumormedicineHumansEpithelial–mesenchymal transitionFibroblastBiologyCell Proliferationlcsh:RProteinsEpithelial Cellsmedicine.diseaseActinsIdiopathic Pulmonary Fibrosisrespiratory tract diseasesGene Expression RegulationchemistryCyclooxygenase 2Immune SystemCase-Control StudiesImmunologic Techniquesbiology.proteinCancer researchClinical Immunologylcsh:QCyclooxygenaseBiomarkersPLoS ONE
researchProduct

Microvascular in vivo assessment of reperfusion injury: significance of prostaglandin E1 and I2 in postischemic “no-reflow” and “reflow-paradox”

2004

Microvascular ischemia-reperfusion (I/R) injury is characterized by failure of capillary perfusion ("no-reflow") and reoxygenation-associated phenomena ("reflow-paradox"), including activation of leukocyte-endothelium interaction with cytotoxic mediator-induced loss of endothelial integrity. The objectives of this study were to elucidate the impact of both prostaglandins E(1) (PGE(1)) and I(2) (PGI(2)) in microvascular reperfusion injury, with special focus on the distinct pathophysiology of no-reflow- and reflow-paradox phenomena.By use of the hamster dorsal skinfold preparation and in vivo fluorescence microscopy, the microcirculation of a striated skin muscle was assessed before 4 h of p…

Pathologymedicine.medical_specialtyEndotheliummedicine.medical_treatmentIschemiaPharmacologyMicrocirculationCapillary Permeabilitychemistry.chemical_compoundIn vivoCricetinaemedicineAnimalsVascular Diseasescardiovascular diseasesAlprostadilMuscle SkeletalProstaglandin E1SkinMicroscopyMesocricetusbusiness.industryMicrocirculationmedicine.diseaseEpoprostenolPathophysiologyCapillariesChemotaxis Leukocytemedicine.anatomical_structurechemistryReperfusion InjuryModels Animalcardiovascular systemSurgeryEndothelium VascularbusinessReperfusion injuryPlatelet Aggregation InhibitorsProstaglandin EJournal of Surgical Research
researchProduct

Changes in crevicular cytokines after application of melatonin in patients with periodontal disease

2017

Background A clinical trial was designed to evaluate the effects of topical application of melatonin on the crevicular fluid levels of interleukins and prostaglandins and to evaluate changes in clinical parameters. Material and methods A consecutive sample of 90 patients were recruited from the Health Centre of Pinos Puente in Granada, Spain and divided into 3 groups: 30 patients with diabetes and periodontal disease, who were given melatonin; 30 patients with diabetes and periodontal disease, who were given a placebo, and 30 healthy individuals with no history of systemic disease or clinical signs of periodontal disease, who were also given a placebo. The 30 patients with diabetes and peri…

Periodontitismedicine.medical_specialtySystemic diseasebusiness.industryResearchInterleukin030206 dentistrymedicine.diseasePlacebo:CIENCIAS MÉDICAS [UNESCO]GastroenterologyMelatoninClinical trial03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicineUNESCO::CIENCIAS MÉDICASmedicinePeriodontologyProstaglandin E2businessGeneral Dentistry030217 neurology & neurosurgerymedicine.drug
researchProduct

Prostanoid receptors of the EP3 subtype mediate inhibition of evoked [3 H]acetylcholine release from isolated human bronchi

1998

1 The release of neuronal [3H]acetylcholine (ACh) from isolated human bronchi after labelling with [3H]choline was measured to investigate the effects of prostanoids. 2 A first period of electrical field stimulation (S1) caused a [3H]ACh release of 320±70 and 200±40 Becquerel (Bq) g−1 in epithelium-denuded and epithelium-containing bronchi respectively (P>0.05). Subsequent periods of electrical stimulation (Sn, n=2, 3, and 4) released less [3H]ACh, i.e. decreasing Sn/S1 values were obtained (0.76±0.09, 0.68±0.07 and 0.40±0.04, respectively). 3 Cumulative concentrations (1–1000 nM) of EP-receptor agonists like prostaglandin E2, nocloprost, and sulprostone (EP1 and EP3 selective) inhibited ev…

PharmacologyAgonistmedicine.medical_specialtybiologyChemistrymedicine.drug_classProstanoidStimulationchemistry.chemical_compoundEndocrinologyInternal medicinebiology.proteinmedicinelipids (amino acids peptides and proteins)CyclooxygenaseProstaglandin E2ReceptorNeurotransmitterAcetylcholinemedicine.drugBritish Journal of Pharmacology
researchProduct

Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages

2001

Phagocytosis of unopsonized zymosan by RAW 264.7 macrophages upregulated protein expression of haem oxygenase-1 (HO-1), inducible nitric oxide synthase (iNOS) and cyclo-oxygenase-2 (COX-2) in a time- and concentration-dependent manner. In the presence of zymosan, exogenous prostaglandin E(2) (PGE(2)) did not exert significant effects on the expression of these three enzymes. In contrast, exogenous leukotriene B(4) (LTB(4)) and LTC(4) in the nanomolar range inhibited HO-1 and iNOS expression, as well as nitrite accumulation. The COX inhibitors indomethacin and NS398 weakly inhibited HO-1 expression but had no effect on iNOS and COX-2 expression or nitrite. In contrast, the 5-lipoxygenase (5-…

PharmacologyCellular immunitybiologyLeukotriene B4medicine.medical_treatmentZymosanZileutonMolecular biologyNitric oxideNitric oxide synthasechemistry.chemical_compoundchemistryBiochemistryArachidonate 5-lipoxygenasebiology.proteinmedicineProstaglandin Emedicine.drugBritish Journal of Pharmacology
researchProduct

Antiasthmatic effects of gamma linolenic acid -high dose Evening Primrose Oil and Borage Oil stimulate allergen tachyphylaxis of sensitized guinea pi…

2012

Summary Evening primose oil (EPO) and borage oil (BO), which contain high amounts of gamma linolenic acid (10% or 20%) and are described to stimulate prostaglandin E biosynthesis, were investigated in guinea pigs for their ability to stimulate an important active self protecting mechanism against allergens (“allergen tachyphylaxis”). Groups of 12 guinea pigs sensitized to ovalbumin were fed over five days with either EPO or BO (100mg/kg/day or 1 g/kg/day) prior to sequential allergen inhalation challenges (time 0′, 10′, 20′, 60′, 70′ and 80′). Bronchial obstruction was measured by whole body plethysmography. 100 mg/kg EPO did not alter the bronchial reactions of the animals; 100 mg and 1 g/…

PharmacologyInhalationbiologybusiness.industrymedicine.medical_treatmentPharmaceutical Sciencerespiratory systemPharmacologyTachyphylaxismedicine.disease_causeAllergic sensitizationOvalbuminchemistry.chemical_compoundAllergenComplementary and alternative medicinechemistryDrug DiscoveryImmunologybiology.proteinMolecular MedicineMedicineEvening Primrose Oilgamma-Linolenic acidbusinessProstaglandin EPhytomedicine
researchProduct

Prostaglandin production by human polymorphnuclear leucocytes during phagocytosis in vitro.

1977

Human polymorphonuclear leukocytes were found to be able to synthetize and release substantial amounts of PGE2' when stimulated by a phagocytic stimulus such as zymosan particles coated with complement. Hydrocortisone, at a concentration of 10(-5) M, which proved to be effective in other biological systems, failed to inhibit phagocytosis and PG release.

PharmacologyPolymorphonuclear leukocyteNeutrophilsPhagocytosismedicine.medical_treatmentProstaglandins EZymosanProstaglandin productionZymosanProstaglandinCell BiologyIn Vitro TechniquesIn vitroMicrobiologyCellular and Molecular Neurosciencechemistry.chemical_compoundchemistryPhagocytosisImmunologymedicineMolecular MedicineHumansMolecular BiologyProstaglandin EExperientia
researchProduct

Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-αby inhibiting nuclear factor-κB activation

2003

The marine product cacospongionolide B, a sesterterpene isolated from the Mediterranean sponge Fasciospongia cavernosa, is an inhibitor of secretory phospholipase A2 with anti-inflammatory properties. In this work, we have studied the mechanism of action of this compound in the inflammatory response induced by zymosan in primary cells and in the mouse air pouch. In mouse peritoneal macrophages, cacospongionolide B was able to downregulate the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), resulting in decreased production of NO and prostaglandin E2 (PGE2). This compound also reduced tumour necrosis factor-α (TNF-α) mRNA expression and TNF-α levels. Cacosp…

Pharmacologymedicine.medical_specialtyNecrosisbiologyZymosanNFKB1Molecular biologyNitric oxide synthasechemistry.chemical_compoundEndocrinologyMechanism of actionchemistryInternal medicinemedicinebiology.proteinTumor necrosis factor alphamedicine.symptomProstaglandin E2Transcription factormedicine.drugBritish Journal of Pharmacology
researchProduct